{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:54:06Z","timestamp":1792220046499,"version":"4.4.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T00:00:00Z","timestamp":1763683200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05356-9","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T07:15:09Z","timestamp":1763709309000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Fluvoxamine Attenuates Blood\u2013Brain Barrier Disruption in Drug-Resistance Epilepsy and inhibits Ferroptosis via the Sigma-1 Receptor-TAMM41 signaling in bEnd.3 cells"],"prefix":"10.1007","volume":"63","author":[{"given":"Lin","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlun","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinting","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhidong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congcong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,21]]},"reference":[{"key":"5356_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2023.120766","volume":"452","author":"B Mesraoua","year":"2023","unstructured":"Mesraoua B, Brigo F, Lattanzi S, Abou-Khalil B, Al Hail H, Asadi-Pooya AA (2023) Drug-resistant epilepsy: definition, pathophysiology, and management. J Neurol Sci 452:120766. https:\/\/doi.org\/10.1016\/j.jns.2023.120766","journal-title":"J Neurol Sci"},{"issue":"18","key":"5356_CR2","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1080\/14656566.2022.2128670","volume":"23","author":"S Elkommos","year":"2022","unstructured":"Elkommos S, Mula M (2022) Current and future pharmacotherapy options for drug-resistant epilepsy. Expert Opin Pharmacother 23(18):2023\u20132034. https:\/\/doi.org\/10.1080\/14656566.2022.2128670","journal-title":"Expert Opin Pharmacother"},{"issue":"9","key":"5356_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1097\/NEN.0b013e31826809a6","volume":"71","author":"Z Michalak","year":"2012","unstructured":"Michalak Z, Lebrun A, Di Miceli M, Rousset MC, Crespel A, Coubes P, Henshall DC, Lerner-Natoli M et al (2012) IgG leakage may contribute to neuronal dysfunction in drug-refractory epilepsies with blood-brain barrier disruption. J Neuropathol Exp Neurol 71(9):826\u2013838. https:\/\/doi.org\/10.1097\/NEN.0b013e31826809a6","journal-title":"J Neuropathol Exp Neurol"},{"key":"5356_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241612689","author":"Y Zabrodskaya","year":"2023","unstructured":"Zabrodskaya Y, Paramonova N, Litovchenko A, Bazhanova E, Gerasimov A, Sitovskaya D, Nezdorovina V, Kravtsova S et al (2023) Neuroinflammatory dysfunction of the blood-brain barrier and basement membrane dysplasia play a role in the development of drug-resistant epilepsy. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms241612689","journal-title":"Int J Mol Sci"},{"issue":"5","key":"5356_CR5","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1111\/epi.17929","volume":"65","author":"JT Reiter","year":"2024","unstructured":"Reiter JT, Schulte F, Bauer T, David B, Endler C, Isaak A, Schuch F, Bitzer F et al (2024) Evidence for interictal blood-brain barrier dysfunction in people with epilepsy. Epilepsia 65(5):1462\u20131474. https:\/\/doi.org\/10.1111\/epi.17929","journal-title":"Epilepsia"},{"issue":"6","key":"5356_CR6","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1038\/s41580-024-00703-5","volume":"25","author":"SJ Dixon","year":"2024","unstructured":"Dixon SJ, Olzmann JA (2024) The cell biology of ferroptosis. Nat Rev Mol Cell Biol 25(6):424\u2013442. https:\/\/doi.org\/10.1038\/s41580-024-00703-5","journal-title":"Nat Rev Mol Cell Biol"},{"key":"5356_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fncel.2021.696889","volume":"15","author":"Y Cai","year":"2021","unstructured":"Cai Y, Yang Z (2021) Ferroptosis and its role in epilepsy. Front Cell Neurosci 15:696889. https:\/\/doi.org\/10.3389\/fncel.2021.696889","journal-title":"Front Cell Neurosci"},{"issue":"10","key":"5356_CR8","doi-asserted-by":"publisher","first-page":"7354","DOI":"10.1007\/s12035-024-04018-6","volume":"61","author":"F Feng","year":"2024","unstructured":"Feng F, Luo R, Mu D, Cai Q (2024) Ferroptosis and pyroptosis in epilepsy. Mol Neurobiol 61(10):7354\u20137368. https:\/\/doi.org\/10.1007\/s12035-024-04018-6","journal-title":"Mol Neurobiol"},{"key":"5356_CR9","doi-asserted-by":"publisher","unstructured":"Liu X, Chen J (2022) Research progress on ferroptosis and its role in epilepsy. J Physiol Pharmacol 73 (6). https:\/\/doi.org\/10.26402\/jpp.2022.6.02","DOI":"10.26402\/jpp.2022.6.02"},{"key":"5356_CR10","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.freeradbiomed.2021.12.268","volume":"179","author":"KN Chen","year":"2022","unstructured":"Chen KN, Guan QW, Yin XX, Wang ZJ, Zhou HH, Mao XY (2022) Ferrostatin-1 obviates seizures and associated cognitive deficits in ferric chloride-induced posttraumatic epilepsy via suppressing ferroptosis. Free Radic Biol Med 179:109\u2013118. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2021.12.268","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"5356_CR11","doi-asserted-by":"publisher","first-page":"e14596","DOI":"10.1111\/cns.14596","volume":"30","author":"X Shi","year":"2024","unstructured":"Shi X, Liu R, Wang Y, Yu T, Zhang K, Zhang C, Gu Y, Zhang L et al (2024) Inhibiting acid-sensing ion channel exerts neuroprotective effects in experimental epilepsy via suppressing ferroptosis. CNS Neurosci Ther 30(2):e14596. https:\/\/doi.org\/10.1111\/cns.14596","journal-title":"CNS Neurosci Ther"},{"issue":"5","key":"5356_CR12","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202201765R","volume":"37","author":"Q Liu","year":"2023","unstructured":"Liu Q, Song T, Chen B, Zhang J, Li W (2023) Ferroptosis of brain microvascular endothelial cells contributes to hypoxia-induced blood-brain barrier injury. FASEB J 37(5):e22874. https:\/\/doi.org\/10.1096\/fj.202201765R","journal-title":"FASEB J"},{"key":"5356_CR13","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.bbrc.2022.06.040","volume":"619","author":"J Fang","year":"2022","unstructured":"Fang J, Yuan Q, Du Z, Fei M, Zhang Q, Yang L, Wang M, Yang W et al (2022) Ferroptosis in brain microvascular endothelial cells mediates blood-brain barrier disruption after traumatic brain injury. Biochem Biophys Res Commun 619:34\u201341. https:\/\/doi.org\/10.1016\/j.bbrc.2022.06.040","journal-title":"Biochem Biophys Res Commun"},{"key":"5356_CR14","doi-asserted-by":"publisher","first-page":"118506","DOI":"10.1016\/j.envres.2024.118506","volume":"250","author":"C Li","year":"2024","unstructured":"Li C, Chen X, Du Z, Geng X, Li M, Yang X, Bo C, Jia Q et al (2024) Inhibiting ferroptosis in brain microvascular endothelial cells: a potential strategy to mitigate polystyrene nanoplastics-induced blood-brain barrier dysfunction. Environ Res 250:118506. https:\/\/doi.org\/10.1016\/j.envres.2024.118506","journal-title":"Environ Res"},{"issue":"1","key":"5356_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","volume":"18","author":"S Pushpakom","year":"2019","unstructured":"Pushpakom S, Iorio F, Eyers PA, Escott KJ, Hopper S, Wells A, Doig A, Guilliams T et al (2019) Drug repurposing: progress, challenges and recommendations. Nat Rev Drug Discov 18(1):41\u201358. https:\/\/doi.org\/10.1038\/nrd.2018.168","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"5356_CR16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.2174\/2589977514666220214120403","volume":"14","author":"N Selvaraj","year":"2022","unstructured":"Selvaraj N, Swaroop AK, Nidamanuri BSS, Kumar RR, Natarajan J, Selvaraj J (2022) Network-based drug repurposing: a critical review. Curr Drug Res Rev 14(2):116\u2013131. https:\/\/doi.org\/10.2174\/2589977514666220214120403","journal-title":"Curr Drug Res Rev"},{"issue":"1","key":"5356_CR17","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1038\/s41467-018-05116-5","volume":"9","author":"F Cheng","year":"2018","unstructured":"Cheng F, Desai RJ, Handy DE, Wang R, Schneeweiss S, Barabasi AL, Loscalzo J (2018) Network-based approach to prediction and population-based validation of in silico drug repurposing. Nat Commun 9(1):2691. https:\/\/doi.org\/10.1038\/s41467-018-05116-5","journal-title":"Nat Commun"},{"issue":"4","key":"5356_CR18","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/FBP.0000000000000127","volume":"26","author":"MW Alhaj","year":"2015","unstructured":"Alhaj MW, Zaitone SA, Moustafa YM (2015) Fluvoxamine alleviates seizure activity and downregulates hippocampal GAP-43 expression in pentylenetetrazole-kindled mice: role of 5-HT3 receptors. Behav Pharmacol 26(4):369\u2013382. https:\/\/doi.org\/10.1097\/FBP.0000000000000127","journal-title":"Behav Pharmacol"},{"issue":"2","key":"5356_CR19","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/ame2.12341","volume":"8","author":"J Ji","year":"2025","unstructured":"Ji J, Gao C, Wang Q, Jia X, Tian H, Wei Y, Liu Z, Wang Y et al (2025) The sigma-1 receptor-TAMM41 axis modulates neuroinflammation and attenuates memory impairment during the latent period of epileptogenesis. Anim Model Exp Med 8(2):197\u2013208. https:\/\/doi.org\/10.1002\/ame2.12341","journal-title":"Anim Model Exp Med"},{"issue":"6","key":"5356_CR20","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/epi.14190","volume":"59","author":"Z Koneval","year":"2018","unstructured":"Koneval Z, Knox KM, White HS, Barker-Haliski M (2018) Lamotrigine-resistant corneal-kindled mice: a model of pharmacoresistant partial epilepsy for moderate-throughput drug discovery. Epilepsia 59(6):1245\u20131256. https:\/\/doi.org\/10.1111\/epi.14190","journal-title":"Epilepsia"},{"issue":"3","key":"5356_CR21","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/ame2.12131","volume":"3","author":"S Kumar","year":"2020","unstructured":"Kumar S, Goel RK (2020) Pharmacokinetic, pharmacodynamic, and neurochemical investigations of lamotrigine-pentylenetetrazole kindled mice to ascertain it as a reliable model for clinical drug-resistant epilepsy. Anim Model Exp Med 3(3):245\u2013255. https:\/\/doi.org\/10.1002\/ame2.12131","journal-title":"Anim Model Exp Med"},{"issue":"1","key":"5356_CR22","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12859-021-04076-w","volume":"22","author":"G Fiscon","year":"2021","unstructured":"Fiscon G, Paci P (2021) Saverunner: an R-based tool for drug repurposing. BMC Bioinformatics 22(1):150. https:\/\/doi.org\/10.1186\/s12859-021-04076-w","journal-title":"BMC Bioinformatics"},{"issue":"5","key":"5356_CR23","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/bcpt.12238","volume":"115","author":"E Singh","year":"2014","unstructured":"Singh E, Pillai KK, Mehndiratta M (2014) Characterization of a lamotrigine-resistant kindled model of epilepsy in mice: evaluation of drug resistance mechanisms. Basic Clin Pharmacol Toxicol 115(5):373\u2013378. https:\/\/doi.org\/10.1111\/bcpt.12238","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"5356_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2019.107750","volume":"167","author":"M Barker-Haliski","year":"2020","unstructured":"Barker-Haliski M, Steve White H (2020) Validated animal models for antiseizure drug (ASD) discovery: advantages and potential pitfalls in ASD screening. Neuropharmacology 167:107750. https:\/\/doi.org\/10.1016\/j.neuropharm.2019.107750","journal-title":"Neuropharmacology"},{"issue":"3","key":"5356_CR25","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1002\/epi4.12354","volume":"4","author":"CS Metcalf","year":"2019","unstructured":"Metcalf CS, Huff J, Thomson KE, Johnson K, Edwards SF, Wilcox KS (2019) Evaluation of antiseizure drug efficacy and tolerability in the rat lamotrigine-resistant amygdala kindling model. Epilepsia Open 4(3):452\u2013463. https:\/\/doi.org\/10.1002\/epi4.12354","journal-title":"Epilepsia Open"},{"key":"5356_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jep.2018.01.032","volume":"216","author":"R Ohno","year":"2018","unstructured":"Ohno R, Miyagishi H, Tsuji M, Saito A, Miyagawa K, Kurokawa K, Takeda H (2018) Yokukansan, a traditional Japanese herbal medicine, enhances the anxiolytic effect of fluvoxamine and reduces cortical 5-HT(2A) receptor expression in mice. J Ethnopharmacol 216:89\u201396. https:\/\/doi.org\/10.1016\/j.jep.2018.01.032","journal-title":"J Ethnopharmacol"},{"issue":"1","key":"5356_CR27","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s10020-024-00791-1","volume":"30","author":"Y Zou","year":"2024","unstructured":"Zou Y, Zhang J, Sun F, Xu Q, Chen L, Luo X, Wang T, Zhou Q et al (2024) Fluvoxamine inhibits Th1 and Th17 polarization and function by repressing glycolysis to attenuate autoimmune progression in type 1 diabetes. Mol Med 30(1):23. https:\/\/doi.org\/10.1186\/s10020-024-00791-1","journal-title":"Mol Med"},{"issue":"9","key":"5356_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/cns.70054","volume":"30","author":"YY Jiang","year":"2024","unstructured":"Jiang YY, Wu WL, Huang JN, Liu N, Wang J, Wan XR, Qin ZH, Wang Y (2024) KA-mediated excitotoxicity induces neuronal ferroptosis through activation of ferritinophagy. CNS Neurosci Ther 30(9):e70054. https:\/\/doi.org\/10.1111\/cns.70054","journal-title":"CNS Neurosci Ther"},{"key":"5356_CR29","doi-asserted-by":"publisher","first-page":"1520876","DOI":"10.3389\/fmolb.2024.1520876","volume":"11","author":"KI Kirkwood-Donelson","year":"2024","unstructured":"Kirkwood-Donelson KI, Jarmusch AK, Bortner CD, Merrick BA, Sinha BK (2024) Metabolic consequences of erastin-induced ferroptosis in human ovarian cancer cells: an untargeted metabolomics study. Front Mol Biosci 11:1520876. https:\/\/doi.org\/10.3389\/fmolb.2024.1520876","journal-title":"Front Mol Biosci"},{"issue":"2","key":"5356_CR30","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/s41418-019-0380-z","volume":"27","author":"L Wang","year":"2020","unstructured":"Wang L, Liu Y, Du T, Yang H, Lei L, Guo M, Ding HF, Zhang J et al (2020) ATF3 promotes erastin-induced ferroptosis by suppressing system Xc(). Cell Death Differ 27(2):662\u2013675. https:\/\/doi.org\/10.1038\/s41418-019-0380-z","journal-title":"Cell Death Differ"},{"issue":"11","key":"5356_CR31","doi-asserted-by":"publisher","first-page":"7349","DOI":"10.1111\/jcmm.14594","volume":"23","author":"T Bai","year":"2019","unstructured":"Bai T, Lei P, Zhou H, Liang R, Zhu R, Wang W, Zhou L, Sun Y (2019) Sigma-1 receptor protects against ferroptosis in hepatocellular carcinoma cells. J Cell Mol Med 23(11):7349\u20137359. https:\/\/doi.org\/10.1111\/jcmm.14594","journal-title":"J Cell Mol Med"},{"issue":"9","key":"5356_CR32","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1038\/nprot.2014.138","volume":"9","author":"R Jafari","year":"2014","unstructured":"Jafari R, Almqvist H, Axelsson H, Ignatushchenko M, Lundback T, Nordlund P, Martinez Molina D (2014) The cellular thermal shift assay for evaluating drug target interactions in cells. Nat Protoc 9(9):2100\u20132122. https:\/\/doi.org\/10.1038\/nprot.2014.138","journal-title":"Nat Protoc"},{"issue":"6","key":"5356_CR33","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1038\/s41401-025-01486-x","volume":"46","author":"L Guo","year":"2025","unstructured":"Guo L, Lv N, Ji JL, Gao C, Liu SY, Liu ZY, Lin XT, Liu ZD et al (2025) Circular RNA hsa_circ_0000288 protects against epilepsy in mice by binding to and stabilizing caprin1 protein. Acta Pharmacol Sin 46(6):1592\u20131609. https:\/\/doi.org\/10.1038\/s41401-025-01486-x","journal-title":"Acta Pharmacol Sin"},{"issue":"2","key":"5356_CR34","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1111\/epi.13994","volume":"59","author":"S Sivapalarajah","year":"2018","unstructured":"Sivapalarajah S, Krishnakumar M, Bickerstaffe H, Chan Y, Clarkson J, Hampden-Martin A, Mirza A, Tanti M et al (2018) The prescribable drugs with efficacy in experimental epilepsies (PDE3) database for drug repurposing research in epilepsy. Epilepsia 59(2):492\u2013501. https:\/\/doi.org\/10.1111\/epi.13994","journal-title":"Epilepsia"},{"key":"5356_CR35","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.bbr.2015.10.019","volume":"297","author":"S Rozenblit-Susan","year":"2016","unstructured":"Rozenblit-Susan S, Chapnik N, Genzer Y, Froy O (2016) Serotonin suppresses food anticipatory activity and synchronizes the food-entrainable oscillator during time-restricted feeding. Behav Brain Res 297:150\u2013154. https:\/\/doi.org\/10.1016\/j.bbr.2015.10.019","journal-title":"Behav Brain Res"},{"issue":"8","key":"5356_CR36","first-page":"595","volume":"42","author":"P Bo","year":"1987","unstructured":"Bo P, Patrucco M, Maurelli M, Camana C, Savoldi F (1987) Influence of L-5-hydroxytryptophan and DL-p-chlorophenylalanine on neurophysiological profiles of serotonin reuptake inhibitors in rabbits. Farmaco Sci 42(8):595\u2013601","journal-title":"Farmaco Sci"},{"issue":"22","key":"5356_CR37","doi-asserted-by":"publisher","first-page":"3198","DOI":"10.1021\/acschemneuro.2c00629","volume":"13","author":"L Guo","year":"2022","unstructured":"Guo L, Gao T, Jia X, Gao C, Tian H, Wei Y, Lu W, Liu Z et al (2022) SKF83959 attenuates memory impairment and depressive-like behavior during the latent period of epilepsy via allosteric activation of the Sigma-1 receptor. ACS Chem Neurosci 13(22):3198\u20133209. https:\/\/doi.org\/10.1021\/acschemneuro.2c00629","journal-title":"ACS Chem Neurosci"},{"issue":"1","key":"5356_CR38","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12987-019-0166-1","volume":"17","author":"L Barna","year":"2020","unstructured":"Barna L, Walter FR, Harazin A, Bocsik A, Kincses A, Tubak V, Josvay K, Zvara A et al (2020) Simvastatin, edaravone and dexamethasone protect against kainate-induced brain endothelial cell damage. Fluids Barriers CNS 17(1):5. https:\/\/doi.org\/10.1186\/s12987-019-0166-1","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"5356_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10571-022-01197-5","volume":"43","author":"Y Zhao","year":"2023","unstructured":"Zhao Y, Liu Y, Xu Y, Li K, Zhou L, Qiao H, Xu Q, Zhao J (2023) The role of ferroptosis in blood-brain barrier injury. Cell Mol Neurobiol 43(1):223\u2013236. https:\/\/doi.org\/10.1007\/s10571-022-01197-5","journal-title":"Cell Mol Neurobiol"},{"issue":"5","key":"5356_CR40","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, Patel DN, Bauer AJ et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149(5):1060\u20131072. https:\/\/doi.org\/10.1016\/j.cell.2012.03.042","journal-title":"Cell"},{"issue":"4","key":"5356_CR41","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/S0893-133X(00)00116-0","volume":"23","author":"NR Bolo","year":"2000","unstructured":"Bolo NR, Hode Y, Nedelec JF, Laine E, Wagner G, Macher JP (2000) Brain pharmacokinetics and tissue distribution in vivo of fluvoxamine and fluoxetine by fluorine magnetic resonance spectroscopy. Neuropsychopharmacology 23(4):428\u2013438. https:\/\/doi.org\/10.1016\/S0893-133X(00)00116-0","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"5356_CR42","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1111\/bph.13692","volume":"174","author":"S Hasebe","year":"2017","unstructured":"Hasebe S, Ago Y, Watabe Y, Oka S, Hiramatsu N, Tanaka T, Umehara C, Hashimoto H, et al. (2017) Anti-anhedonic effect of selective serotonin reuptake inhibitors with affinity for sigma-1 receptors in picrotoxin-treated mice. Br J Pharmacol 174(4):314\u2013327. https:\/\/doi.org\/10.1111\/bph.13692","journal-title":"Br J Pharmacol"},{"key":"5356_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/cells12091233","author":"W Loscher","year":"2023","unstructured":"Loscher W, White HS (2023) Animal models of drug-resistant epilepsy as tools for deciphering the cellular and molecular mechanisms of pharmacoresistance and discovering more effective treatments. Cells. https:\/\/doi.org\/10.3390\/cells12091233","journal-title":"Cells"},{"issue":"3","key":"5356_CR44","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1124\/pr.120.019539","volume":"72","author":"W Loscher","year":"2020","unstructured":"Loscher W, Potschka H, Sisodiya SM, Vezzani A (2020) Drug resistance in epilepsy: clinical impact, potential mechanisms, and new innovative treatment options. Pharmacol Rev 72(3):606\u2013638. https:\/\/doi.org\/10.1124\/pr.120.019539","journal-title":"Pharmacol Rev"},{"issue":"1","key":"5356_CR45","doi-asserted-by":"publisher","first-page":"e2501","DOI":"10.1002\/rmv.2501","volume":"34","author":"J Deng","year":"2024","unstructured":"Deng J, Moskalyk M, Zuo QK, Garcia C, Abbas U, Ramaraju HB, Rayner D, Park YJ et al (2024) Evaluating fluvoxamine for the outpatient treatment of COVID-19: a systematic review and meta-analysis. Rev Med Virol 34(1):e2501. https:\/\/doi.org\/10.1002\/rmv.2501","journal-title":"Rev Med Virol"},{"issue":"1","key":"5356_CR46","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1124\/jpet.102.046532","volume":"305","author":"J Weiss","year":"2003","unstructured":"Weiss J, Dormann SM, Martin-Facklam M, Kerpen CJ, Ketabi-Kiyanvash N, Haefeli WE (2003) Inhibition of P-glycoprotein by newer antidepressants. J Pharmacol Exp Ther 305(1):197\u2013204. https:\/\/doi.org\/10.1124\/jpet.102.046532","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"5356_CR47","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/00004714-199504000-00008","volume":"15","author":"LL von Moltke","year":"1995","unstructured":"von Moltke LL, Greenblatt DJ, Court MH, Duan SX, Harmatz JS, Shader RI (1995) Inhibition of alprazolam and desipramine hydroxylation in vitro by paroxetine and fluvoxamine: comparison with other selective serotonin reuptake inhibitor antidepressants. J Clin Psychopharmacol 15(2):125\u2013131. https:\/\/doi.org\/10.1097\/00004714-199504000-00008","journal-title":"J Clin Psychopharmacol"},{"issue":"2","key":"5356_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1517\/17425250802691074","volume":"5","author":"M Jamei","year":"2009","unstructured":"Jamei M, Marciniak S, Feng K, Barnett A, Tucker G, Rostami-Hodjegan A (2009) The Simcyp population-based ADME simulator. Expert Opin Drug Metab Toxicol 5(2):211\u2013223. https:\/\/doi.org\/10.1517\/17425250802691074","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"11","key":"5356_CR49","doi-asserted-by":"publisher","first-page":"2937","DOI":"10.1111\/epi.17402","volume":"63","author":"JA Mensah","year":"2022","unstructured":"Mensah JA, Johnson K, Reilly CA, Wilcox KS, Rower JE, Metcalf CS (2022) Evaluating the efficacy of prototype antiseizure drugs using a preclinical pharmacokinetic approach. Epilepsia 63(11):2937\u20132948. https:\/\/doi.org\/10.1111\/epi.17402","journal-title":"Epilepsia"},{"issue":"5","key":"5356_CR50","first-page":"782","volume":"28","author":"W Loscher","year":"1978","unstructured":"Loscher W, Esenwein H (1978) Pharmacokinetics of sodium valproate in dog and mouse. Arzneimittelforschung 28(5):782\u2013787","journal-title":"Arzneimittelforschung"},{"issue":"6","key":"5356_CR51","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1177\/1091581817735987","volume":"36","author":"Y Kusunoki","year":"2017","unstructured":"Kusunoki Y, Kido Y, Naito Y, Kon R, Mizukami N, Kaneko M, Wakui N, Machida Y et al (2017) Changes in the pharmacokinetics of Phenytoin in dextran sulfate sodium-induced ulcerative colitis in mice. Int J Toxicol 36(6):485\u2013491. https:\/\/doi.org\/10.1177\/1091581817735987","journal-title":"Int J Toxicol"},{"issue":"4","key":"5356_CR52","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/S0090-9556(25)06578-X","volume":"23","author":"LL Radulovic","year":"1995","unstructured":"Radulovic LL, Turck D, von Hodenberg A, Vollmer KO, McNally WP, DeHart PD, Hanson BJ, Bockbrader HN et al (1995) Disposition of gabapentin (Neurontin) in mice, rats, dogs, and monkeys. Drug Metab Dispos 23(4):441\u2013448","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"5356_CR53","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/j.bbr.2004.08.015","volume":"158","author":"R Arban","year":"2005","unstructured":"Arban R, Maraia G, Brackenborough K, Winyard L, Wilson A, Gerrard P, Large C (2005) Evaluation of the effects of lamotrigine, valproate and carbamazepine in a rodent model of mania. Behav Brain Res 158(1):123\u2013132. https:\/\/doi.org\/10.1016\/j.bbr.2004.08.015","journal-title":"Behav Brain Res"},{"issue":"6","key":"5356_CR54","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/epi.13394","volume":"57","author":"FM Noe","year":"2016","unstructured":"Noe FM, Bellistri E, Colciaghi F, Cipelletti B, Battaglia G, de Curtis M, Librizzi L (2016) Kainic acid-induced albumin leak across the blood-brain barrier facilitates epileptiform hyperexcitability in limbic regions. Epilepsia 57(6):967\u2013976. https:\/\/doi.org\/10.1111\/epi.13394","journal-title":"Epilepsia"},{"key":"5356_CR55","doi-asserted-by":"publisher","first-page":"149011","DOI":"10.1016\/j.brainres.2024.149011","volume":"1838","author":"R Tan","year":"2024","unstructured":"Tan R, Sui C, Diao Y, Shi G, Hu X, Hao Z, Li C, Hao M et al (2024) Activation of the sigma-1 receptor ameliorates neuronal ferroptosis via IRE1alpha after spinal cord injury. Brain Res 1838:149011. https:\/\/doi.org\/10.1016\/j.brainres.2024.149011","journal-title":"Brain Res"},{"issue":"5","key":"5356_CR56","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1083\/jcb.200603087","volume":"174","author":"Y Tamura","year":"2006","unstructured":"Tamura Y, Harada Y, Yamano K, Watanabe K, Ishikawa D, Ohshima C, Nishikawa S, Yamamoto H et al (2006) Identification of Tam41 maintaining integrity of the TIM23 protein translocator complex in mitochondria. J Cell Biol 174(5):631\u2013637. https:\/\/doi.org\/10.1083\/jcb.200603087","journal-title":"J Cell Biol"},{"issue":"3","key":"5356_CR57","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.bbalip.2017.12.005","volume":"1863","author":"NJ Blunsom","year":"2018","unstructured":"Blunsom NJ, Gomez-Espinosa E, Ashlin TG, Cockcroft S (2018) Mitochondrial CDP-diacylglycerol synthase activity is due to the peripheral protein, TAMM41 and not due to the integral membrane protein, CDP-diacylglycerol synthase 1. Biochimica et Biophysica Acta (BBA) 1863(3):284\u2013298. https:\/\/doi.org\/10.1016\/j.bbalip.2017.12.005","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"2","key":"5356_CR58","doi-asserted-by":"publisher","first-page":"100097","DOI":"10.1016\/j.xhgg.2022.100097","volume":"3","author":"K Thompson","year":"2022","unstructured":"Thompson K, Bianchi L, Rastelli F, Piron-Prunier F, Ayciriex S, Besmond C, Hubert L, Barth M et al (2022) Biallelic variants in TAMM41 are associated with low muscle cardiolipin levels, leading to neonatal mitochondrial disease. HGG Adv 3(2):100097. https:\/\/doi.org\/10.1016\/j.xhgg.2022.100097","journal-title":"HGG Adv"},{"key":"5356_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1301822","volume":"10","author":"C Fu","year":"2023","unstructured":"Fu C, Cao N, Zeng S, Zhu W, Fu X, Liu W, Fan S (2023) Role of mitochondria in the regulation of ferroptosis and disease. Front Med 10:1301822. https:\/\/doi.org\/10.3389\/fmed.2023.1301822","journal-title":"Front Med"},{"issue":"5","key":"5356_CR60","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1038\/s41418-024-01280-y","volume":"31","author":"SI Yamashita","year":"2024","unstructured":"Yamashita SI, Sugiura Y, Matsuoka Y, Maeda R, Inoue K, Furukawa K, Fukuda T, Chan DC et al (2024) Mitophagy mediated by BNIP3 and NIX protects against ferroptosis by downregulating mitochondrial reactive oxygen species. Cell Death Differ 31(5):651\u2013661. https:\/\/doi.org\/10.1038\/s41418-024-01280-y","journal-title":"Cell Death Differ"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05356-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05356-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05356-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T07:15:10Z","timestamp":1763709310000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05356-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,21]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5356"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05356-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,21]]},"assertion":[{"value":"20 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal care and experimental protocols were conducted in accordance with the ethical principles for animal research and approved by the Institutional Animal Care and Use Committee of Xuzhou University (Approval No. 202209S057) and were in compliance with the Guidelines for the Care and Use of Laboratory Animals (Chinese-National-Research-Council, 2006) and with the 'ARRIVE' guidelines (Animals in Research: Reporting In VivoExperiments). Procedures were designed to minimize animal pain and distress, including the use of appropriate anesthesia and regular welfare monitoring.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Permission to Reproduce Material from other Sources"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient Consent Statement"}},{"value":"None of the authors has any conflict of interest to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest Disclosure"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}}],"article-number":"120"}}